11 April 2023 in Orphanet Journal of Rare Diseases
Background: Traditional clinical trials require tests and procedures that are administered in centralized clinical research sites, which are beyond the standard of care that patients receive for their rare and chronic diseases. The limited number of rare disease patients scattered around the world makes it particularly challenging to recruit participants and conduct these traditional clinical trials. Main body: Participating in clinical research can be burdensome, especially for children, the elderly, physically and cognitively impaired individuals who require transportation and caregiver assistance, or patients who live in remote locations or cannot afford transportation. In recent years, there is an increasing need to consider Decentralized Clinical Trials (DCT) as a participant-centric approach that uses new technologies and innovative procedures for interaction with participants in the comfort of their home. Conclusion: This paper discusses the planning and conduct of DCTs, which can increase the quality of trials with a specific focus on rare diseases.
21 October 2020 in JMIR Rehabilitation and Assistive Technologies
Background: Measuring free-living gait using wearable devices may offer higher granularity and temporal resolution than the current clinical assessments for patients with Parkinson disease (PD). However, increasing the number of devices worn on the body adds to the patient burden and impacts the compliance. Objective: This study aimed to investigate the impact of reducing the number of wearable devices on the ability to assess gait impairments in patients with PD. Methods: A total of 35 volunteers with PD and 60 healthy volunteers performed a gait task during 2 clinic visits. Participants with PD were assessed in the On and Off medication state using the Movement Disorder Society version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS). Gait features derived from a single lumbar-mounted accelerometer were compared with those derived using 3 and 6 wearable devices for both participants with PD and healthy participants. Results: A comparable performance was observed for predicting the MDS-UPDRS gait score using longitudinal mixed-effects model fit with gait features derived from a single (root mean square error [RMSE]=0.64; R2=0.53), 3 (RMSE=0.64; R2=0.54), and 6 devices (RMSE=0.54; R2=0.65). In addition, MDS-UPDRS gait scores predicted using all 3 models differed significantly between On and Off motor states (single device, P=.004; 3 devices, P=.004; 6 devices, P=.045). Conclusions: We observed a marginal benefit in using multiple devices for assessing gait impairments in patients with PD when compared with gait features derived using a single lumbar-mounted accelerometer. The wearability burden associated with the use of multiple devices may offset gains in accuracy for monitoring gait under free-living conditions.
12 December 2025 in Journal of Medical Internet Research
Background: Digital health technologies, such as accelerometry, offer low participant burden and provide quantitative metrics with ease of deployment, making them increasingly popular for gait monitoring. Remote gait monitoring delivers quantifiable, continuous health measures over extended periods, surpassing the limited insights from single clinic or laboratory visits and offering a more comprehensive health perspective. Numerous gait algorithm implementations, inspired by prior research, aim to standardize these metrics across devices. The SciKit Digital Health (SKDH) package exemplifies this as a device-agnostic framework. Objective: This study introduces a series of literature-informed enhancements to the SKDH gait algorithm, improving its performance against reference standards and reducing the need for manual parameter adjustments across diverse populations. Methods: A block-wise refinement process was undertaken, examining each algorithmic component for potential enhancements and evaluating their cumulative impact on the complete gait algorithm and the metrics generated. Results: Using data from healthy adult and pediatric participants, the novel gait event estimation method reduced the mean absolute error by more than 50% compared with its predecessor. Following the updates, the intraclass correlation values for final gait metric concordance with the in-laboratory reference improved markedly, from 0.50-0.74 to 0.81-0.90. Additionally, the systematic bias observed in the previous version’s gait speed estimation was rectified, narrowing the difference from the reference from 0.065-0.230 to 0.00-0.03 m/s. Conclusions: The findings from this study provide robust evidence supporting the validity of the enhancements made to the gait algorithm. They demonstrate that a single lumbar accelerometer can capture gait characteristics with high accuracy and reliability across various speeds and age groups.